Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263. https://doi.org/10.3322/caac.21834

Article  PubMed  Google Scholar 

Welch HG, Albertsen PC (2009) Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Natl Cancer Inst 101(19):1325–1329. https://doi.org/10.1093/jnci/djp278

Article  PubMed  PubMed Central  Google Scholar 

De Vrieze M, Al-Monajjed R, Boschheidgen M et al (2024) Prostate cancer screening in young men. J Pers Med. https://doi.org/10.3390/jpm14080818

Article  PubMed  PubMed Central  Google Scholar 

Burri RJ, Ho AY, Forsythe K et al (2010) Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 77(5):1315–1321. https://doi.org/10.1016/j.ijrobp.2009.06.052

Article  PubMed  Google Scholar 

Magheli A, Rais-Bahrami S, Humphreys EB et al (2007) Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol 178(5):1933–1937. https://doi.org/10.1016/j.juro.2007.07.016

Article  PubMed  Google Scholar 

Nguyen TD, Poortmans PM, van der Hulst M et al (2005) The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective study. Radiother Oncol 77(3):286–289. https://doi.org/10.1016/j.radonc.2005.10.015

Article  PubMed  Google Scholar 

Pettersson A, Robinson D, Garmo H et al (2018) Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study. Ann Oncol 29(2):377–385. https://doi.org/10.1093/annonc/mdx742

Article  PubMed  CAS  Google Scholar 

Salinas CA, Tsodikov A, Ishak-Howard M et al (2014) Prostate cancer in young men: an important clinical entity. Nat Rev Urol 11(6):317–323. https://doi.org/10.1038/nrurol.2014.91

Article  PubMed  PubMed Central  CAS  Google Scholar 

Alibhai SM, Krahn MD, Cohen MM et al (2004) Is there age bias in the treatment of localized prostate carcinoma? Cancer 100(1):72–81. https://doi.org/10.1002/cncr.11884

Article  PubMed  Google Scholar 

Wang Z, Ni Y, Chen J et al (2020) The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis. World J Surg Oncol 18(1):42. https://doi.org/10.1186/s12957-020-01824-9

Article  PubMed  PubMed Central  Google Scholar 

Eastham JA, Auffenberg GB, Barocas DA et al (2022) Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management. J Urol 208(1):10–18. https://doi.org/10.1097/JU.0000000000002757

Article  PubMed  Google Scholar 

Rosser CJ, Chichakli R, Levy LB et al (2002) Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation. J Urol 168(2):536–541

Article  PubMed  Google Scholar 

Klayton TL, Ruth K, Horwitz EM et al (2011) Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer. Radiother Oncol 101(3):508–512. https://doi.org/10.1016/j.radonc.2011.07.022

Article  PubMed  PubMed Central  Google Scholar 

Zelefsky MJ, Marion C, Fuks Z et al (2003) Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. J Urol 170(5):1828–1832. https://doi.org/10.1097/01.ju.0000093720.46502.24

Article  PubMed  Google Scholar 

D’Amico AV, Whittington R, Schultz D et al (1997) Outcome based staging for clinically localized adenocarcinoma of the prostate. J Urol 158(4):1422–1426

Article  PubMed  Google Scholar 

Roach M 3rd, Hanks G, Thames H Jr. et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys 65(4):965–974. https://doi.org/10.1016/j.ijrobp.2006.04.029

Article  PubMed  Google Scholar 

Falagario UG, Abbadi A, Remmers S et al (2023) Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy. JAMA Netw Open 6(9):e2332900. https://doi.org/10.1001/jamanetworkopen.2023.32900

Article  PubMed  PubMed Central  Google Scholar 

Sooriakumaran P, Nyberg T, Akre O et al (2014) Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. BMJ 348:g1502. https://doi.org/10.1136/bmj.g1502

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hamdy FC, Donovan JL, Lane JA et al (2023) Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 388(17):1547–1558. https://doi.org/10.1056/NEJMoa2214122

Article  PubMed  Google Scholar 

Beesley LJ, Morgan TM, Spratt DE et al (2019) Individual and population comparisons of surgery and radiotherapy outcomes in prostate cancer using bayesian multistate models. JAMA Netw Open 2(2):e187765. https://doi.org/10.1001/jamanetworkopen.2018.7765

Article  PubMed  PubMed Central  Google Scholar 

Hamdy FC, Donovan JL, Lane JA et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375(15):1415–1424. https://doi.org/10.1056/NEJMoa1606220

Article  PubMed  Google Scholar 

Valle LF, Lehrer EJ, Markovic D et al (2021) A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER). Eur Urol 80(3):280–292. https://doi.org/10.1016/j.eururo.2020.11.010

Article  PubMed  Google Scholar 

Ingrosso G, Becherini C, Lancia A et al (2020) Nonsurgical salvage local therapies for radiorecurrent prostate cancer: a systematic review and meta-analysis. Eur Urol Oncol 3(2):183–197. https://doi.org/10.1016/j.euo.2018.12.011

Article  PubMed  Google Scholar 

Onal C, Guler OC, Elmali A et al (2024) The impact of age on clinicopathological features and treatment results in patients with localised prostate cancer receiving definitive radiotherapy. Acta Oncol 63:858–866. https://doi.org/10.2340/1651-226x.2024.40759

Article  PubMed  Google Scholar 

Zamboglou C, Aebersold DM, Albrecht C et al (2025) The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the prostate cancer working group of the german society of radiation oncology (DEGRO). Strahlenther Onkol 201(1):4–10. https://doi.org/10.1007/s00066-024-02288-6

Article  PubMed  CAS  Google Scholar 

Freedman GM, Hanlon AL, Lee WR, Hanks GE (1996) Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. Int J Radiat Oncol Biol Phys 35(2):243–250. https://doi.org/10.1016/0360-3016(96)00017-x

Article  PubMed  CAS  Google Scholar 

Tan L, Wang LL, Ranasinghe W et al (2018) Survival outcomes of younger men (〈 55 years) undergoing radical prostatectomy. Prostate Int 6(1):31–35. https://doi.org/10.1016/j.prnil.2017.07.002

Article  PubMed  Google Scholar 

Milonas D, Venclovas Z, Gudinaviciene I et al (2017) Long-term oncological outcomes for young men undergoing radical prostatectomy for localized prostate cancer. Biomed Res Int 2017:9858923. https://doi.org/10.1155/2017/9858923

Article  PubMed  PubMed Central  Google Scholar 

Rosser CJ, Kamat AM, Wang X et al (2006) Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy. Urology 67(4):769–773. https://doi.org/10.1016/j.urology.2005.10.027

Article  PubMed  Google Scholar 

Roupret M, Fromont G, Bitker MO et al (2006) Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology 67(5):1028–1032.